Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells

Neuropathology

Volumn 30, Issue 1, 2010, Pages 44-49

  Leães, Carolina Garcia Soares ^a   Meurer, Rosalva Theresa ^a   Coutinho, Lígia Barbosa ^a   Ferreira, Nelson Pires ^a   Pereira Lima, Júlia Fernanda Semmelmann ^a   Da Costa Oliveira, Miriam ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Androgen; Aromatase; Estrogen; Meningioma; Progesterone; Receptors

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; AROMATASE; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARACHNOID; ARACHNOID CYST; ARTICLE; BRAIN SURGERY; BRAZIL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; GENETIC HETEROGENEITY; HISTOLOGY; HOSPITAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MENINX; NEUROSURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARACHNOID; ARACHNOID CYSTS; AROMATASE; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; MIDDLE AGED; ODDS RATIO; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 74949084038     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2009.01047.x     Document Type: Article

References (46)

1. Brueggemeier RW, Hackett JC, Diaz-Cruz ES. Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 2005 26 : 331 345.
2. Segawa T, Shozu M, Murakami K et al. Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival. Clin Cancer Res 2005 11 : 2188 2194.
3. Cunat S, Rabenoelina F, Daures JP et al. Aromatase expression in ovarian epithelial cancers. J Steroid Biochem Mol Biol 2005 93 : 15 24.
4. Mensah-Nyagan AG, Do-Rego JL, Beaujean D, Luu-The V, Pelletier G, Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev 1999 51 : 63 81.
5. Lephart ED. A review of brain aromatase cytochrome P450. Brain Res Rev 1996 22 : 1 26.
6. Azcoitia I, Sierra A, Veiga S, Garcia-Segura LM. Aromatase expression by reactive astroglia is neuroprotective. Ann NY Acad Sci 2003 1007 : 298 305.
7. Zwain IH, Yen SS, Cheng CY. Astrocytes cultured in vitro produce estradiol-17beta and express aromatase cytochrome P450 mRNA. Biochem Biophys Acta 1997 1334 : 338 348.
8. Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE, Hutchison JB. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 1999 89 : 567 578.
9. Peterson RS, Saldanha CJ, Schlinger BA. Rapid upregulation of aromatase mRNA and protein following neural injury in the zebra finch (Taeniopygia guttata). J Neuroendocrinol 2001 13 : 317 323.
10. Melcangi RC, Panzica G. Steroids and the nervous system. Introduction. Ann NY Acad Sci 2003 1007 : 1 5.
11. Harada N, Yamada K, Foidart A, Balthazart J. Regulation of aromatase cytochrome P450 (estrogen synthetase) transcripts in the quail brain by testosterone. Mol Brain Res 1992 15 : 19 26.
12. Tsuruo Y. Topography and function of androgen-metabolizing enzymes in the central nervous system. Anat Sci Int 2005 80 : 1 11.
13. Hardy DB, Janowski BA, Chen CC, Mendelson CR. Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms. Mol Endocrinol 2008 22 : 1812 1824.
14. Altundag K, Ibrahim NK. Aromatase inhibitors in breast cancer: an overview. Oncologist 2006 11 : 553 562.
15. Lantos PL, Louis DN, Rosenblum MK, Kleihues P. Tumours of the nervous system. In : Graham DI, Lantos PL, eds. Greenfield's Neuropathology. London : Arnold, 2002 767.
16. Milenkovic S, Berisavac J, Cvetkovic-Dozic D, Skender-Gazibara M, Bojovic V, Berisavac I. Hormone receptors in benign intracranial meningiomas. J BUON 2004 9 : 295 298.
17. Louis DN, Ohgaki H, Wiestler OD et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007 114 : 97 109.
18. Osborn AG. Diagnostic Neuroradiology. St Louis : Mosby, 1994.
19. Aguiar PHP, Ramina R, Veiga JCE, Tella O Jr. Meningiomas: Diagnóstico e tratamento clínico e cirúrgico: aspectos atuais. Rio de Janeiro : Livraria e Editora Revinter Ltda, 2006.
20. Pei I, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997 11 : 433 441.
21. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann NY Acad Sci 2003 1007 : 64 78.
22. Carretero J, Vazquez G, Rubio M et al. Postnatal differentiation of the immunohistochemical expression of aromatase P450 in the rat pituitary gland. Histol Histopathol 2003 18 : 419 423.
23. Lambard S, Galeraud-Denis I, Bouraima H, Bourguiba S, Chocat A, Carreau S. Expression of aromatase in human ejaculated spermatozoa: a putative marker of motility. Mol Hum Reprod 2003 9 : 117 124.
24. Negri-Cesi P, Colciago A, Pravettoni A, Casati L, Conti L, Celotti F. Sexual differentiation of the rodent hypothalamus: hormonal and environmental influences. J Steroid Biochem Mol Biol 2008 109 : 294 299.
25. Singer CF, Fink-Retter A, Gschwantler-Kaulich D et al. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism. Endocr Relat Cancer 2006 13 : 1101 1107.
26. Song D, Liu G, Luu-The V et al. Expression of aromatase and 17-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study. J Steroid Biochem Mol Biol 2006 101 : 136 144.
27. Bochkareva NV, Kolomiets LA, Kondakova IV, Stukanov SL, Starova AB, Agarkova LA. Enzymes of estrogen metabolism in endometrial cancer. Bull Exp Biol Med 2006 141 : 240 242.
28. Nair HB, Luthra R, Kirma N et al. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Res 2005 65 : 11164 11173.
29. Carretero J, Burks DJ, Vazquez G et al. Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Pituitary 2002 5 : 5 10.
30. Weinberg OK, Marquez-Garban DC, Fishbein MC et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res 2005 65 : 11287 11291.
31. Yang S, Liu R, Wu SS, Simpkins JW. The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann NY Acad Sci 2003 1007 : 101 107.
32. Carswell HV, Dominiczak AF, Garcia-Segura LM, Harada N, Hutchison JB, Macrae IM. Brain aromatase expression after experimental stroke: topography and time course. J Steroid Biochem Mol Biol 2005 96 : 89 91.
33. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN. Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 1993 78 : 456 462.
34. Carroll RS, Glowacka D, Dashner K, Black PM. Progesterone receptor expression in meningiomas. Cancer Res 1993 53 : 1312 1316.
35. Hilbig A, Barbosa-Coutinho LM. Meningiomas and hormonal receptors. Immunohistochemical study in typical and non-typical tumors. Arq Neuropsiquiatr 1998 56 : 193 199.
36. Omulecka A, Papierz W, Nawrocka-Kunecka A, Lewy-Trenda I. Immunohistochemical expression of progesterone and estrogen receptors in Meningiomas. Folia Neuropathol 2006 44 : 111 115.
37. Claus EB, Park PJ, Carroll R, Chan J, Black PM. Specific genes expressed in association with progesterone receptors in meningiomas. Cancer Res 2008 68 : 314 322.
38. Takei H, Buckleair LW, Powell S. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Neuropathology 2008 28 : 62 68.
39. Chen J, Chen G. Expression of androgen receptor in meningiomas. J Tongji Med Univ 2001 21 : 140 142.
40. Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasolo H. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 2006 80 : 1 7.
41. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 2004 57 : 1033 1037.
42. Rubinstein AB, Louen D, Geier A, Reichenthal E, Gadoth N. Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg 1994 81 : 184 187.
43. Konstantinidou AE, Korkolopoulou P, Mahera H et al. Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 2003 43 : 280 290.
44. Pravdenkova S, Al-Mefty O, Sawyer J, Hussain M. Progesterone and estrogen receptors: opposing prognostic indicators in Meningiomas. J Neurosurg 2006 105 : 163 173.
45. Balthazart J, Stoop R, Foidart A, Granneman JCM, Lambert JGD. Distribution and regulation of estrogen-2-hydroxylase in the quail brain. Brain Res Bull 1994 35 : 339 345.
46. Strobl-Mazzulla PH, Lethimonier C, Gueguen MM, Karube M, Kah O, Somoza GM. Brain aromatase (Cyp19A2) and estrogen receptors, in larvae and adult pejerrey fish Odontesthes bonariensis: neuroanatomical and functional relations. Gen Comp Endocrinol 2008 158 : 191 201.